21Division

21 Manufacture of basic pharmaceutical products and pharmaceutical preparations

Sub-categories (2)

Financial AggregatesFY 2024

€356,441,208

Total Revenue

Employees

€539,800,893

Total Assets

€396,898,313

Total Equity

11.3%

Profit Margin

10.1%

ROE

€113,048

Revenue / Employee

€78,509

Median Revenue

1.5

Median Employees

€133,887

Median Assets

€37,918

Median Equity

2.3%

Median Profit Margin

7.6%

Median ROE

#	Company	Total Revenue	Employees	Profit Margin
1	Akciju sabiedrība "GRINDEKS"	€181,822,263	1K	-1.8%
2	Akciju sabiedrība "Olpha"	€126,874,000	1K	30.5%
3	Sabiedrība ar ierobežotu atbildību "PHARMIDEA"	€8,554,000	119	2.3%
4	Sabiedrība ar ierobežotu atbildību "LMP"	€6,027,640	19	47.3%
5

No companies found for this NACE code.

NACE Rev.2/2.1, VID tax data 2022–2024